Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide, in which mitochondrial DNA (mtDNA) released by damaged hepatocytes activates neutrophils via the binding of TLR9, further aggravating liver injury. Here, we demonstrated that mtDNA/TLR9 also activates a negative feedback pathway via the induction of microRNA-223 (miR-223) to limit neutrophil over-activation and liver injury. After injection of APAP in mice, levels of miR-223, the most abundant miRNAs in neutrophils, were highly elevated in neutrophils. Disruption of the miR-223 gene exacerbated APAP-induced hepatic neutrophil infiltration, oxidative stress, and injury, and enhanced TLR9 ligand-mediated activation of pro-inflammatory mediators in neutrophils. An additional deletion of the intercellular adhesion molecule 1 (ICAM-1) gene ameliorated APAP-induced neutrophil infiltration and liver injury in miR-223 knockout mice. In vitro experiments revealed that miR-223-deficient neutrophils were more susceptible to TLR9 agonist-mediated induction of pro-inflammatory mediators and NF-κB signaling; whereas overexpression of miR-223 attenuated these effects in neutrophils. Moreover, inhibition of TLR9 signaling via either treatment with a TLR9 inhibitor or via the disruption of TLR9 gene partially but significantly suppressed miR-223 expression in neutrophils post APAP injection. In contrast, activation of TLR9 upregulated miR-223 expression in neutrophils in vivo and in vitro. Mechanistically, activation of TLR9 upregulated miR-223 by enhancing NF-κB binding on miR-223 promoter; while miR-223 attenuated TLR9/NF-κB-mediated inflammation by targeting IKKα expression. Collectively, upregulation of miR-223 plays a key role in terminating the acute neutrophilic response and is a therapeutic target for the treatment of APAP-induced liver failure.